Becton Dickinson (BDX)
NYSEHealth CareMedical - Instruments & SuppliesSnapshot 2026-11-04
$213.55+2.08%
Close 2026-11-05 · 1-day change
NYSEHealth CareMedical - Instruments & SuppliesSnapshot 2026-11-04
QuarterlyIQ Insights · BDX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 8.0% |
| Our one-year growth estimate | diamond | -4.7% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 12.7 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 11 industry peers · Company calendar date is not available
BDX — President transition
Dated 2026-07-22
Executive Vice President and President of the Medical Essentials and BioPharma Systems segments — Michael D. Garrison: Michael D. Garrison intends to retire and a search for his successor is underway.
Why it matters: BD raised its EPS outlook twice, but its latest midpoint is $12.67. A higher outlook would back its growth and margin plan.
Supportive ifIn its next results, BD raises the fiscal 2026 adjusted EPS midpoint above $12.67.
Worry ifBD lowers its fiscal 2026 adjusted EPS midpoint below $12.67.
Why it matters: BD repaid $2.1 billion of debt and carried out a $2.0 billion share buyback in Q2. New details will show how it uses cash after the spin-off.
Watch forBD reports more debt repayment and keeps share buybacks within its announced $2 billion plan.
Also watch forBD reports no further debt repayment and pauses or cuts planned share buybacks.
Why it matters: The sector has been in a maturing phase, with growth slowing. A rise back toward recent highs would improve the sector backdrop for BD.
Supportive ifHealth Care sector revenue growth rises back toward its recent highs from near 9%.
Worry ifHealth Care sector revenue growth stays near 9% or falls further.
Why it matters: Fiscal Q3 revenue grew 4.4% after currency effects. Slower growth would weaken the recent momentum signal.
Worry ifFiscal Q4 revenue growth after currency effects falls below 4.4% year over year.
Less concerning ifFiscal Q4 revenue growth after currency effects reaches or exceeds 4.4% year over year.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$98 on $10,000 · ±1.0% | How much price usually moves either way. |
| Bad day | $222 loss on $10,000 · 2.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,361 loss on $10,000 · 23.6% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: BD has pledged $2.5 billion for U.S. plants over five years. Reported spending or new plant milestones would show progress on that commitment.
Watch forBD reports plant spending or a named milestone tied to its $2.5 billion, five-year U.S. investment plan.
Also watch forBD reports a delay, cut, or cancellation of the $2.5 billion U.S. plant investment plan.